Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

WHI-P233, a new cytotoxic melamine derivative

Feb. 8, 2001

Progen concludes phase Ib evaluation of PI-88

Feb. 8, 2001

Novel fluoroindolocarbazoles formed in rebeccamycin-producing microorganism

Feb. 8, 2001

Isolation, structure determination and cytotoxic activity of AJI-9561

Feb. 8, 2001

Novel DNA crosslinker with potential in the treatment of cisplatin-resistant ovarian cancer

Feb. 8, 2001

Phase II study examines IMC-C225 in combination with other agents for NSCLC

Feb. 8, 2001

NewBiotics and Elan form joint venture to develop colon cancer therapy

Feb. 8, 2001

Japanese labs design new series of ribonucleotide reductase inhibitors

Feb. 7, 2001

YM BioSciences extends EGF cancer vaccine trial to include U.K. sites

Feb. 7, 2001

Results with INGN-201 indicate new strategy for cancer immunotherapy

Feb. 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...